GCTK

GlucoTrack Inc · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website glucotrack.com
Employees(FY) 3
ISIN US45824Q6061

Performance

+5.2%

+15.19%

-89.95%

-87.35%

-77.55%

YTD

-75.25%

Profile

GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Advanced Technical Analysis

Technical Analysis of GCTK 2024-12-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 36 indicating a bearish outlook, while the Oscillators Score of 56 suggests a neutral stance, and the overall Technical Score of 46 reinforces a neutral sentiment. This combination implies that while there are some bearish signals, the market is not strongly negativ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of GCTK

Stock Rank

Recent News & Updates

2024-12-02 19:30
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR(Globenewswire)
2024-11-14 03:30
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt(Globenewswire)
2024-11-12 20:00
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering(Globenewswire)
2024-10-21 21:00
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE(Globenewswire)
2024-09-30 21:00
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING(Globenewswire)
2024-09-02 21:00
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS(Globenewswire)
2024-08-26 21:00
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS(Globenewswire)
2024-08-14 21:00
Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference(Globenewswire)
2024-08-04 21:00
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE(Globenewswire)
2024-07-31 04:00
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR(Globenewswire)
2024-06-19 20:30
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS(Globenewswire)
2024-06-12 21:19
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR(Globenewswire)
2024-06-10 22:50
Sidoti Events, LLC's Virtual June Small-Cap Conference(Accesswire)
2024-06-09 22:50
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE(Globenewswire)
2024-06-04 20:30
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR(Globenewswire)
2024-05-17 02:52
GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024(Investorplace)
2024-05-15 20:30
GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY(Globenewswire)
2024-05-15 04:15
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT(Globenewswire)
2024-05-01 21:00
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION(Globenewswire)
2024-04-28 19:33
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-04-24 14:18
Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK)(Yahoo Finance)
2024-04-22 02:10
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT(Globenewswire)
2024-04-15 20:30
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING(Globenewswire)
2024-04-02 19:00
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now(Globenewswire)
2024-04-01 20:30
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR(Globenewswire)
2024-04-01 19:00
Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now(Globenewswire)
2024-03-11 21:30
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY(Globenewswire)
2024-02-26 19:30
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR(Globenewswire)
2024-02-12 20:30
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAV TO CHAIR OF THE BOARD OF DIRECTORS(Globenewswire)
2024-02-06 18:00
Presenting on the Emerging Growth Conference 67 Day 2 on February 8 Register Now(Globenewswire)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.